Percheron Therapeutics Ltd. engages in the research and development of novel antisense pharmacceuticals. It operates through the ATL1102, and ATL1103 segments. The ATL1102 segment represents the second generation antisense inhibitor of CD49d, the alpha subunit of very late antigen-four. The ATL1103 segment refers to atesidorsen is an antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin. The company was founded on November 13, 2000 and is headquartered in Toorak, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Percheron Therapeutics Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Percheron Therapeutics Ltd. market cap is $12.51M.
What is the 52-week high for Percheron Therapeutics Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Percheron Therapeutics Ltd. 52 week high is $0.0566 as of September 06, 2025.
What is the 52-week low for Percheron Therapeutics Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Percheron Therapeutics Ltd. 52 week low is $0.0018 as of September 06, 2025.
What is Percheron Therapeutics Ltd. stock price today?
Percheron Therapeutics Ltd. stock price today is $0.0115.
What was Percheron Therapeutics Ltd. stock price yesterday?
Percheron Therapeutics Ltd. stock price yesterday was $0.0025.
What is the PE ratio of Percheron Therapeutics Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Percheron Therapeutics Ltd.’s P/E ratio is -1.17.
What is the Price-to-Book ratio of Percheron Therapeutics Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Percheron Therapeutics Ltd. P/B ratio is 1.9071.
What is the 50-day moving average of Percheron Therapeutics Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Percheron Therapeutics Ltd. 50-day moving average is $0.0076.
